These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Nelfinavir access in Canada.
    Journal: TreatmentUpdate; 1998 Sep; 10(7):6, 8. PubMed ID: 11365783.
    Abstract:
    Due to the licensing of Nelfinavir in Canada, Agouron Pharmaceuticals will stop enrolling subjects into its Nelfinavir expanded access program. Current participants will continue receiving the drug under the program for up to 90 days following licensing or when private insurance coverage is granted. A toll-free number is provided for those needing help with finding payment options for Nelfinavir.
    [Abstract] [Full Text] [Related] [New Search]